FDA NDC Directory · JSON-LD · Markdown

DEFERASIROX

NDC 31722-031 · HUMAN PRESCRIPTION DRUG · GRANULE

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA216229
Dosage form / routeGRANULE · ORAL
Active ingredientsDEFERASIROX (360 mg/1)
Marketing started20220922
Package count1

External sources

Source: openFDA. Public-domain (CC0).